Back to Search
REYNA BOCANEGRA, PHARMD
PHARMD
Pharmacist
NPI: 1548062433Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
30230(MD)
Research & Publications (20)
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
PMID 19289523·Antimicrob Agents Chemother·2009
7-preclinical
Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
PMID 18658194·J Antimicrob Chemother·2008
4-observational
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
PMID 18474582·Antimicrob Agents Chemother·2008
7-preclinical
Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
PMID 18397335·Clin Microbiol Infect·2008
7-preclinical
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
PMID 18160526·Antimicrob Agents Chemother·2008
7-preclinical
New guinea pig model of Cryptococcal meningitis.
PMID 17562797·Antimicrob Agents Chemother·2007
7-preclinical
Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
PMID 17360039·J Infect·2007
7-preclinical
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.
PMID 17307976·Antimicrob Agents Chemother·2007
7-preclinical
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
PMID 17005844·Antimicrob Agents Chemother·2006
7-preclinical
In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis.
PMID 16569882·Antimicrob Agents Chemother·2006
7-preclinical
Monodisperse structured multi-vesicle microencapsulation using flow-focusing and controlled disturbance.
PMID 16421085·J Microencapsul·2005
8-other
Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.
PMID 16304187·Antimicrob Agents Chemother·2005
7-preclinical
Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana.
PMID 15855484·Antimicrob Agents Chemother·2005
7-preclinical
Antifungal therapy of murine Aspergillus terreus infection.
PMID 15388425·Antimicrob Agents Chemother·2004
7-preclinical
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.
PMID 15155236·Antimicrob Agents Chemother·2004
7-preclinical
Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis.
PMID 15155212·Antimicrob Agents Chemother·2004
4-observational
Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis.
PMID 15047549·Antimicrob Agents Chemother·2004
5-case
Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories.
PMID 14982761·Antimicrob Agents Chemother·2004
4-observational
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
PMID 12972452·J Antimicrob Chemother·2003
7-preclinical
Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis.
PMID 12821503·Antimicrob Agents Chemother·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 165 ORVILLE RD
ESSEX, MD 21221 - Phone
- (410) 238-1064
Quick Facts
- NPI
- 1548062433
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile